Axsome Therapeutics (AXSM) Cash from Operations (2015 - 2026)
Axsome Therapeutics recorded quarterly Cash from Operations of 20700000.0 in Q1 2026, down 10.97% quarter-over-quarter from 18653000.0 in Q4 2025, and up 52.28% year-over-year from 13593679.03 in Q1 2025.
Axsome Therapeutics' Cash from Operations history runs 12 years deep, the most recent figure standing at 20700000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 52.28% year-over-year to 20700000.0; the TTM figure through Mar 2026 stood at 70730000.0 (up 40.22% YoY), while the FY2025 annual figure was 93405000.0, up 27.26% from the prior year.
- Cash from Operations came in at 20700000.0 for Q1 2026 at Axsome Therapeutics, down from 18653000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1046000.0 in Q3 2025 to a low of 55349000.0 in Q2 2023.
- A 5-year average of 29653294.12 and a median of 30110000.0 in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 818.52% in 2024 and jumped 105.61% in 2025, its largest moves.
- Axsome Therapeutics' Cash from Operations stood at 27563000.0 in 2022, then retreated by 10.15% to 30362000.0 in 2023, then grew by 13.7% to 26202000.0 in 2024, then increased by 28.81% to 18653000.0 in 2025, then declined by 10.97% to 20700000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 20700000.0, 18653000.0, and 1046000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -20.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.70 Mn |
| Mar 31, 2026 | -20.70 Mn |
| Dec 31, 2025 | -18.65 Mn |
| Dec 31, 2025 | -18.65 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | -32.42 Mn |
| Jun 30, 2025 | -32.42 Mn |
| Mar 31, 2025 | -43.38 Mn |
| Mar 31, 2025 | -43.38 Mn |
| Dec 31, 2024 | -26.20 Mn |
| Dec 31, 2024 | -26.20 Mn |
| Sep 30, 2024 | -18.63 Mn |
| Sep 30, 2024 | -18.63 Mn |
| Jun 30, 2024 | -30.11 Mn |
| Jun 30, 2024 | -30.11 Mn |
| Mar 31, 2024 | -53.47 Mn |
| Mar 31, 2024 | -53.47 Mn |
| Dec 31, 2023 | -30.36 Mn |
| Dec 31, 2023 | -30.36 Mn |
| Sep 30, 2023 | -53.55 Mn |
| Sep 30, 2023 | -53.55 Mn |
| Jun 30, 2023 | -55.35 Mn |
| Jun 30, 2023 | -55.35 Mn |
| Mar 31, 2023 | -5.82 Mn |
| Mar 31, 2023 | -5.82 Mn |
| Dec 31, 2022 | -27.56 Mn |
| Dec 31, 2022 | -27.56 Mn |
| Sep 30, 2022 | -22.76 Mn |
| Sep 30, 2022 | -22.76 Mn |
| Jun 30, 2022 | -33.54 Mn |
| Jun 30, 2022 | -33.54 Mn |
| Mar 31, 2022 | -32.65 Mn |
| Mar 31, 2022 | -32.65 Mn |
| Dec 31, 2021 | -28.84 Mn |
| Dec 31, 2021 | -28.84 Mn |
| Sep 30, 2021 | -26.78 Mn |
| Sep 30, 2021 | -26.78 Mn |
| Jun 30, 2021 | -25.39 Mn |
| Jun 30, 2021 | -25.39 Mn |
| Mar 31, 2021 | -27.22 Mn |
| Mar 31, 2021 | -27.22 Mn |
| Dec 31, 2020 | -20.55 Mn |
| Dec 31, 2020 | -20.55 Mn |
| Sep 30, 2020 | -15.73 Mn |
| Sep 30, 2020 | -15.73 Mn |
| Jun 30, 2020 | -18.90 Mn |
| Jun 30, 2020 | -18.90 Mn |
| Mar 31, 2020 | -23.27 Mn |
| Mar 31, 2020 | -23.27 Mn |
| Dec 31, 2019 | -17.57 Mn |
| Dec 31, 2019 | -17.57 Mn |
| Sep 30, 2019 | -10.63 Mn |
| Sep 30, 2019 | -10.63 Mn |
| Jun 30, 2019 | -8.68 Mn |
| Jun 30, 2019 | -8.68 Mn |
| Mar 31, 2019 | -9.50 Mn |
| Mar 31, 2019 | -9.50 Mn |
| Dec 31, 2018 | -9.79 Mn |
| Dec 31, 2018 | -9.79 Mn |
| Sep 30, 2018 | -5.91 Mn |
| Sep 30, 2018 | -5.91 Mn |
| Jun 30, 2018 | -7.67 Mn |
| Jun 30, 2018 | -7.67 Mn |
| Mar 31, 2018 | -6.68 Mn |
| Mar 31, 2018 | -6.68 Mn |
| Dec 31, 2017 | -6.29 Mn |
| Dec 31, 2017 | -6.29 Mn |
| Sep 30, 2017 | -6.45 Mn |
| Sep 30, 2017 | -6.45 Mn |
| Jun 30, 2017 | -7.10 Mn |
| Jun 30, 2017 | -7.10 Mn |
| Mar 31, 2017 | -6.64 Mn |
| Mar 31, 2017 | -6.64 Mn |
| Dec 31, 2016 | -7.22 Mn |
| Dec 31, 2016 | -7.22 Mn |
| Sep 30, 2016 | -4.80 Mn |
| Sep 30, 2016 | -4.80 Mn |
| Jun 30, 2016 | -5.31 Mn |
| Jun 30, 2016 | -5.31 Mn |
| Mar 31, 2016 | -3.95 Mn |
| Mar 31, 2016 | -3.95 Mn |
| Dec 31, 2015 | -2.25 Mn |
| Dec 31, 2015 | -2.25 Mn |
| Sep 30, 2015 | -1.92 Mn |
| Sep 30, 2015 | -1.92 Mn |
| Jun 30, 2015 | -2.11 Mn |
| Jun 30, 2015 | -2.11 Mn |
| Mar 31, 2015 | -1.16 Mn |
| Mar 31, 2015 | -1.16 Mn |